Cargando…
Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
Dysregulation of the epigenetic enzyme-mediated transcription of oncogenes or tumor suppressor genes is closely associated with the occurrence, progression, and prognosis of tumors. Based on the reversibility of epigenetic mechanisms, small-molecule compounds that target epigenetic regulation have b...
Autores principales: | Jin, Ye, Liu, Tianjia, Luo, Haoming, Liu, Yangyang, Liu, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995554/ https://www.ncbi.nlm.nih.gov/pubmed/35419278 http://dx.doi.org/10.3389/fonc.2022.848221 |
Ejemplares similares
-
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
por: Kim, Ayoung, et al.
Publicado: (2023) -
Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
por: Ashraf, Waseem, et al.
Publicado: (2023) -
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
por: Montalvo-Casimiro, Michel, et al.
Publicado: (2020) -
Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
por: Ghorbaninejad, Mahsa, et al.
Publicado: (2020) -
Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
por: Rath, Suvasmita, et al.
Publicado: (2021)